G Medical Innovations Holdings Ltd (GMVD)

$3.37

+0.11 (+3.37%)
Rating:
Recommendation:
-
Symbol GMVD
Price $3.37
Beta -1.084
Volume Avg. 0.03M
Market Cap 2.799M
Shares () -
52 Week Range 3.1-235.9
1y Target Est -
DCF Unlevered GMVD DCF ->
DCF Levered GMVD LDCF ->
ROE 667.90% Strong Buy
ROA -221.25% Strong Sell
Operating Margin -
Debt / Equity -274.70% Sell
P/E -2.59 Sell
P/B -11.75 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest GMVD news


Dr. Yacov Geva
Healthcare
Medical Instruments & Supplies
NASDAQ Capital Market

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.